Breast cancer is one of the most common cancers that afflict women. In some parts is the most common malignancy. Currently it is estimated that one in 14 women of all children born will develop breast cancer in their lifetime.

The incidence of breast cancer is increasing in all countries, especially developing countries like India.

For more information please visit stherbb.com

This is because more and more women in India are beginning to work outside the home, allowing the various risk factors for breast cancer come into play. These include late age at first childbirth, fewer children and shorter duration of breastfeeding. Of these, the first is more important.

Read the rest of this entry »

Study Ties Hot Flashes to Lower Breast Cancer Risk

Here’s some good news for women ever bothered by hot flashes and other menopausal symptoms: Your risk for breast cancer may be reduced as much as 50 percent, researchers from the Fred Hutchinson Cancer Research Center in Seattle report.

“We know that hormones are important to breast cancer risk, and we also know that menopausal symptoms occur primarily because of changes in hormones that women experience as they go through menopause,” said lead author and breast cancer epidemiologist Dr. Christopher I. Li.

Now, for the first time, he said researchers looked at the relationship between menopause symptoms and breast cancer risk.

Read the rest of this entry »

Using known risk factors for breast cancer, mathematical models can be developed to help answer important questions.  These mathematical models are useful tools for researchers and for patients as follows:

1. Research on risk factors – The Claus risk assessment model was used to discover the subpopulation of people who had an autosomal dominant genetic allele that increased their risk from 10% to 92%. This led to the discovery of the BRCA genes associated with breast, ovarian, and prostate cancer.
2. Clinical trial eligibility – The Gail risk assessment model was developed to help researchers determine who to enroll in the NSAPB Breast Cancer Prevention Trials

where chemoprevention was shown to reduce breast cancer risk.

3. Guidelines for doing BRCA testing – BRCA testing is very expensive and practically worthless if done on everyone (because it is so rare to be homozygous for BRCA1 or BRCA2). Mathematical models such as the BRCAPRO, BOADICEA, and Tyrer-Cuzick models can help determine what patients should undergo BRCA testing. The decision for testing is usually made when one of these models predicts a 10% or greater chance that there is a mutation of the BRCA1, BRCA2, or both genes.
4. Guidelines for doing MRI screening for breast cancer - MRI screening for breast cancer is not a cost effective screening test for the general population, but in specific groups, there are clear cut reasons to do so. In general, screening MRI is recommended for women with 20-25% or greater lifetime risk of breast cancer. The BRCAPRO and Tyrer-Cuzick models have been used to help make clinical decisions about ordering MRIs for breast cancer screening.
5. Guidelines for breast cancer therapy - The Gail model is used clinically to help
Read the rest of this entry »